Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates


Interstitial lung disease: case report

    • 5 Accesses

    This is a preview of subscription content, log in to check access.


    1. Matsuo T, et al. Successful osimertinib rechallenge after osimertinib-induced interstitial lung disease in a patient with postoperative recurrence of lung cancer. Haigan / Japanese Journal of Lung Cancer 59: 1184-1189, No. 7, 20 Dec 2019. Available from: URL: [Japanese; summarised from an English abstract]

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Osimertinib. Reactions Weekly 1790, 182 (2020).

    Download citation